Amyloïdose Cardiaque

Voici quelques articles en référence:

-Bokhari et al. 2013. (99m)Tc pyrophosphate scintigraphy for differentiating AL CA from the TTR related familial and senile CA Circ Cardiovasc Imaging
-Castano et al. 2016. Multicenter study of planar technitium 99m PYP cardiac imaging. Predicting survival for pts with ATTR CA. JAMA Cardiol
-Gillmore et al. 2016. Nonbiopsy diagnosis of cardiac TTR Amyloidosis. Circulation
-ASNC Amyloid Practice Points 99mTechnetium-PYP imaging for TTR cardiac amyloidosis 2019-Dorbola et al. 2019. ASNC AHA ASE EANM HFSA ISA SCMR SNMMI Expert consensus recommendations for multimodality imaging in CA, Part 1 of 2 Evidence base and standardized imaging. J Nucl Cardiol
-Dorbola et al. 2020. ASNC AHA ASE EANM HFSA ISA SCMR SNMMI Expert consensus recommendations for multimodality imaging in CA, Part 2 of 2 Diagnostic criteria and appropriate utilization. J Nucl Cardiol-Fine et al., 2020. CCS CHFS joint position statement on the evaluation and management of patients with CA. Can J Cardiol
-Maurer et al. 2019. Expert consensus recommendations for the suspicion and diagnosis of TTR CA. Circ Heart Fail
-Witteles et al. 2019 Screening for TTR amyloid cardiomyopathy in everyday practice. JACC HF
– Maurer et al. 2018. Tafamidis treatment for patients with TTR amyloid cardiomyopathy. NEJM